IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10,105 | -35.7% | 1,260,000 | +18.9% | 0.11% | -39.1% |
| Q1 2024 | $15,709 | +42.1% | 1,060,000 | -22.1% | 0.18% | +20.9% |
| Q4 2023 | $11,057 | +78.7% | 1,360,000 | 0.0% | 0.15% | +74.1% |
| Q3 2023 | $6,188 | -35.4% | 1,360,000 | 0.0% | 0.08% | -31.5% |
| Q2 2023 | $9,574 | +15.2% | 1,360,000 | 0.0% | 0.12% | +8.8% |
| Q1 2023 | $8,310 | -4.4% | 1,360,000 | 0.0% | 0.11% | -0.9% |
| Q4 2022 | $8,690 | -99.9% | 1,360,000 | +17.2% | 0.12% | -24.8% |
| Q3 2022 | $11,113,000 | -13.2% | 1,160,000 | 0.0% | 0.15% | -5.0% |
| Q2 2022 | $12,806,000 | +494.0% | 1,160,000 | +411.7% | 0.16% | +496.3% |
| Q1 2019 | $2,156,000 | +7.5% | 226,681 | 0.0% | 0.03% | -6.9% |
| Q4 2018 | $2,006,000 | -55.5% | 226,681 | -43.4% | 0.03% | -50.0% |
| Q3 2018 | $4,507,000 | -8.7% | 400,603 | +3.9% | 0.06% | -14.7% |
| Q2 2018 | $4,934,000 | – | 385,446 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
| Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
| Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
| Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
| Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
| QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
| Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |